Table_4_Probiotic VSL#3 Treatment Reduces Colonic Permeability and Abdominal Pain Symptoms in Patients With Irritable Bowel Syndrome.docx

Table_4_Probiotic VSL#3 Treatment Reduces Colonic Permeability and Abdominal Pain Symptoms in Patients With Irritable Bowel Syndrome.docx

<p>Background: Little is known regarding the clinical impact of treatment and treatment duration of probiotic VSL#3 on gut and microbiome function in irritable bowel syndrome (IBS). As part of a safety trial, we assessed the effect of VSL#3 treatment duration on abdominal pain, stooling, gut p...

Full description

Saved in:
Bibliographic Details
Main Author: Prapaporn Boonma (80485) (author)
Other Authors: Jordan M. Shapiro (11464489) (author), Emily B. Hollister (156772) (author), Shyam Badu (1285002) (author), Qinglong Wu (195500) (author), Erica M. Weidler (8472927) (author), Bincy P. Abraham (11464492) (author), Sridevi Devaraj (7479887) (author), Ruth Ann Luna (8313483) (author), James Versalovic (158351) (author), Margaret M. Heitkemper (9131061) (author), Tor C. Savidge (726121) (author), Robert J. Shulman (2015980) (author)
Published: 2021
Subjects:
Medicine
Cell Biology
Cancer
Anaesthesiology
Physiology not elsewhere classified
irritable bowel syndrome
VSL#3
probiotic
permeability
microbiome
bile acids
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items